Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.
about
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondDepressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling.Long-term neprilysin inhibition - implications for ARNIs.Natriuretic peptides and volume handling in heart failure: the paradigm of a new treatment.The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.
P2860
Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Rationale and therapeutic oppo ...... augmentation in heart failure.
@en
type
label
Rationale and therapeutic oppo ...... augmentation in heart failure.
@en
prefLabel
Rationale and therapeutic oppo ...... augmentation in heart failure.
@en
P2860
P1476
Rationale and therapeutic oppo ...... augmentation in heart failure.
@en
P2093
John C Burnett
P2860
P2888
P356
10.1007/S11897-014-0235-3
P50
P577
2015-02-01T00:00:00Z
P6179
1031193038